混合[18F]FDG-PET检测晚期头颈部鳞状细胞癌复发
该单中心10年回顾性研究纳入285例接受混合PET随访的晚期头颈部癌患者,199例3个月PET阴性者中15%后续复发,其中90%复发由混合PET检出;作者认为多数复发经PET检出,支持随访中定期重复扫描。
要点
- 199例3个月混合PET阴性患者中15%后续出现复发。
- 这些复发中90%由混合PET扫描检出。
- 作者认为多数复发经PET检出,支持随访中定期重复扫描。
核心结论
- 15%的3个月混合PET阴性患者出现复发,且多数复发由混合PET检出,作者认为有理由在随访中纳入定期重复扫描。
研究设计与样本
- 单中心10年回顾性研究,纳入所有因晚期头颈部癌随访接受混合PET扫描的患者,共285例。
主要发现
- 199例3个月混合PET阴性患者中,15%在后续随访期间出现复发。
- 这些复发中90%由混合PET检出。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the clinical management of advanced stage head and neck squamous cell carcinoma, the use of hybrid [18F]FDG-PET imaging is well established. However, there is ongoing debate regarding the optimal frequency of hybrid PET scans to be included in follow-up protocols, particularly if the initial post-therapeutic scan is negative. METHODS: We conducted a single-center 10-year retrospective study involving all patients who underwent hybrid PET scans for the follow-up of advanced stage head and neck cancer. A total of 285 patients were included. RESULTS: Out of 199 patients with a negative 3-month hybrid PET, 15% subsequently developed a recurrence during further follow-up. Notably, 90% of these recurrences were detected by hybrid PET. CONCLUSION: Fifteen percent of patients with a negative 3-month hybrid PET experienced a recurrence. Given that the majority of recurrences were detected by hybrid PET scans, there is a compelling argument for incorporating regular repetitive scans during follow-up.
引用
- Sutter OP, Maurer A, Stadler TM, et al. Recurrence Detection by Hybrid [ 18F]FDG-PET in Advanced Head and Neck Squamous Cell Carcinoma. Head Neck. 2024. PMID: 39520038. doi:10.1002/hed.27997
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。